Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-1459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70578 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2017-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019516997-A |
titleOfInvention |
Detection of residual disease in multiple myeloma |
abstract |
The present invention relates to a method for detecting the presence of normal plasma cells and neoplastic plasma cells in a cell sample derived from a patient by flow cytometry. 【Selection chart】 None |
priorityDate |
2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |